Evaluation of signal transduction pathways mediating the nuclear exclusion of the androgen receptor by melatonin

Print
Published on Thursday, 13 November 2014

Abstract

The intracellular signaling pathways mediating the nuclear exclusion of the androgen receptor (AR) by melatonin were evaluated in PC3 cells stably transfected with the AR.

The melatonin-induced nuclear exclusion of the AR by melatonin (100 nM, 3 h) was blocked by LY 83583 (an inhibitor of guanylyl cyclases).

8-Bromo-cGMP (a cell-permeable cGMP analog), mimicked the effect of melatonin, as did ionomycin (a calcium ionophore) and PMA [an activator of protein kinase C (PKC)], and their effects were blocked by GF- 109203X (a selective PKC inhibitor). BAPTA (an intracellular calcium chelator) blocked the effects of melatonin and 8-bromo-cGMP but not of PMA.

Inhibition or activation of the protein kinase A pathway did not affect basal or melatonin-mediated AR localization.

We conclude that the melatonin-mediated rise in cGMP elicits AR nuclear exclusion via a pathway involving increased intracellular calcium and PKC activation.

These results define a novel signaling pathway that regulates AR localization and androgen responses in target cells.

 

 

About this publication.

 

See also About Melatonin.